
Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss Biomed S.A.
Manufacture of pharmaceutical preparations
Overview
Instytut Biotechnologii Surowic I Szczepionek Biom is a Polish pharmaceutical and biotechnology company that produces biological medicines, specialized probiotics, rehydration solutions, and in vitro microbiological diagnostic products. They manufacture a variety of vaccines, including a unique vaccine against Pseudomonas aeruginosa, and ensure high-quality standards through GMP practices. The company collaborates with partners from dozens of countries, providing support for registration, promotion, and distribution of their products.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $3,078,228 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 13 days late). All were audited by a statutory auditor.
- 2025filed
- 202403/07/2025
- 202319/06/2024
- 202230/06/2023
- 202128/07/2022
- 202025/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
Websites
- biomed.plStrona główna – BiomedWordPress 7.1Google Tag ManagerYoast SEOWWPMLApache
- blonicaitezec.info.plTężec i błonica. Strona w trakcie budowyApache
Public procurement
102 tenders recorded as contractor: 57 national ($451,971) and 45 EU ($40,146,570).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 13, 2026 | Open tender PN/13PL/06/2026 for the supply of medicinal products and medical devices | $17,492$17,492 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zakaźny w Warszawie | |
| Nov 13, 2026 | Open tender PN/13PL/06/2026 for the supply of medicinal products and medical devices | $2,898$2,898 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zakaźny w Warszawie | |
| Nov 6, 2026 | Successive supply of medicines to the hospital pharmacy | $1,729$1,729 | Szpital w Ostródzie sp. z o.o. |
The company is the contractor in 60 public sector contracts, worth USD 11.20m in total. They were signed with 39 public buyers. The largest number (3) were signed with Ministerstwo Zdrowia.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 12, 2026 | Supply of consumables. | $117.83 | Gdański Uniwersytet Medyczny | |
| Nov 10, 2026 | Diagnostics | $138.73 | Wojewódzka Stacja Sanitarno-Epidemiologiczna w Gdańsku | |
| Nov 10, 2026 | Supply of sporals | $99.00 | Powiatowa Stacja Sanitarno-Epidemiologiczna |
Trademarks
The company holds 5 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2023.
| Mark | Protected until | |
|---|---|---|
| ORSONUDI (word) | Nov 19, 2035 | |
| LANO GLOW (word) | May 28, 2035 | |
| NUDICOL (word) | Nov 8, 2034 | |
| DENUDIN (word) | Nov 8, 2034 | |
| BRACELAN (word) | Oct 17, 2033 |
Job offers
The company lists 1 job opening on its own careers page: biomed.pl/kariera.
Authorized Representatives
Manner of representation
Joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will and sign on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1997-01-01.
52 1090 1665 0000 0001 5854 8591
82 1090 1665 0000 0001 5017 2295
89 1090 1665 0000 0001 5025 5007
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $711.4K$711,398 |
Buildings and premises | $2.3M$2,273,304 |
MSiG notices
27 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| May 20, 2026 | Shareholders' meeting convened | |
| May 21, 2025 | Shareholders' meeting convened | |
| May 16, 2024 | Shareholders' meeting convened | |
| May 15, 2023 | Shareholders' meeting convened | |
| Jun 24, 2022 | Shareholders' meeting convened |
Public aid
6 public aid cases recorded, with a total value of $3,257,419.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 31, 2026 | Regional investment aid | $2.5M$2,463,433 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Mar 31, 2026 | Training aid | $2,904$2,904 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Oct 17, 2024 | Aid for research and development projects: experimental development | $518K$517,956 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-02-01 | Automation and digitisation of the manufacturing process for critical vaccines DTP, Clodivac, Tetana, DT, D, d and TyT to strengthen the resilience of the EU supply chain | $2.5M$2,466,337 | European Funds for a Modern Economy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Integrated permit | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Tarchomińskie Zakłady Farmaceutyczne Polfa S.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| Medicaline sp. z o.o. | $46,877,712.69 | medicaline.pl | ||
| Phytopharm Klęka S.A. | $46,154,888.31 | phytopharm.pl | ||
| Biogen Poland sp. z o.o. | $42,610,046.12 | biogen-poland.pl | ||
| Natubay sp. z o.o. | $34,559,262.94 | natubay.pl | ||
| Zakłady Farmaceutyczne Colfarm S.A. | $27,692,749.78 | colfarm.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Bio-Gen sp. z o.o. | $17,565,830.56 | bio-gen.pl | ||
| Reig Jofre sp. z o.o. | $16,662,733.82 | reigjofre.pl | ||
| Synthaverse S.A. | $11,561,778.00 | synthaverse.com |
Change history
| Date | Event | |
|---|---|---|
| 2012-11-13 | Share capital reduction (8,200,000.00 PLN → 8,032,700.00 PLN) | |
| 2009-12-23 | Name change (Instytut Biotechnologii Surowic I Szczepionek "biomed" Spółka Akcyjna - Skrót Firmy Ibss Biomed S.a. → Instytut Biotechnologii Surowic I Szczepionek Biomed Spółka Akcyjna - Skrót Firmy Ibss Biomed S.a.) | |
| 2005-07-21 | Name change (Instytut Biotechnologii Surowic I Szczepionek Biomed → Instytut Biotechnologii Surowic I Szczepionek "biomed" Spółka Akcyjna - Skrót Firmy Ibss Biomed S.a.) | |
| 2004-11-09 | Share capital increase (6,500,000.00 PLN → 8,200,000.00 PLN) | |
| 2003-08-19 | Name change (Wytwórnia Surowic I Szczepionek "biomed" → Instytut Biotechnologii Surowic I Szczepionek Biomed) |
FAQ
Last updated: 2026-03-20